Dataset Information


Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV.

ABSTRACT: BACKGROUND:The rapid spread of the coronavirus disease 2019 (COVID-19), caused by a zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a global threat. Awareness of the biological features of 2019-nCoV should be updated in time and needs to be comprehensively summarized to help optimize control measures and make therapeutic decisions. METHODS:Based on recently published literature, official documents and selected up-to-date preprint studies, we reviewed the virology and origin, epidemiology, clinical manifestations, pathology and treatment of 2019-nCoV infection, in comparison with severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) infection. RESULTS:The genome of 2019-nCoV partially resembled SARS-CoV and MERS-CoV, and indicated a bat origin. The COVID-19 generally had a high reproductive number, a long incubation period, a short serial interval and a low case fatality rate (much higher in patients with comorbidities) than SARS and MERS. Clinical presentation and pathology of COVID-19 greatly resembled SARS and MERS, with less upper respiratory and gastrointestinal symptoms, and more exudative lesions in post-mortems. Potential treatments included remdesivir, chloroquine, tocilizumab, convalescent plasma and vaccine immunization (when possible). CONCLUSION:The initial experience from the current pandemic and lessons from the previous two pandemics can help improve future preparedness plans and combat disease progression.


PROVIDER: S-EPMC7118633 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7118423 | BioStudies
| S-EPMC7320676 | BioStudies
| S-EPMC7212949 | BioStudies
| S-EPMC7457039 | BioStudies
2020-01-01 | S-EPMC7459861 | BioStudies
2020-01-01 | S-EPMC7228394 | BioStudies
2020-01-01 | S-EPMC7315836 | BioStudies
2020-01-01 | S-EPMC7471349 | BioStudies
2020-01-01 | S-EPMC7499575 | BioStudies
2020-01-01 | S-EPMC7473886 | BioStudies